.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 9,351,928

« Back to Dashboard

Details for Patent: 9,351,928

Title:Method of making particles for use in a pharmaceutical composition
Abstract: A method for making composite excipient particles for use in a pharmaceutical composition comprises a milling step in which particles of an excipient material are milled in the presence of an additive material. The product particles are of small size and the milling requires relatively low input of time and energy. The composite particles are suitable for use in inhalable pharmaceutical compositions.
Inventor(s): Staniforth; John Nicholas (Bath, GB), Morton; David Alexander Vodden (Bath, GB), Musa; Rossella (Parma, IT)
Assignee: VECTURA LIMITED (Wiltshire, GB)
Filing Date:May 18, 2010
Application Number:12/782,283
Claims:1. Composite excipient particles for use in a pharmaceutical composition, each composite excipient particle comprising a particle of an excipient material and additive material adhering to the surface of that particle of excipient material, wherein 90% by weight of the composite excipient particles have diameter of less than 20 .mu.m determined using the Malvern laser light scattering method, wherein the additive material is in the form of particles coating the surfaces of the particles of excipient material.

2. The composite excipient particles as claimed in claim 1, wherein 90% by weight of the composite excipient particles have a diameter of less than 15 .mu.m.

3. The composite excipient particles as claimed in claim 1, wherein 90% by weight of the composite excipient particles have a diameter of less than 10 .mu.m.

4. The composite excipient particles as claimed in claim 1, wherein the excipient material is a crystalline sugar.

5. The composite excipient particles as claimed in claim 1, in which the additive material comprises an amino acid.

6. The composite excipient particles as claimed in claim 1, in which the additive material comprises a phospholipid.

7. The composite excipient particles as claimed in claim 1, in which the additive material comprises a metal stearate.

8. A pharmaceutical composition comprising composite excipient particles as claimed in claim 1, and active particles.

9. The pharmaceutical composition as claimed in claim 8, wherein the active particles comprise one or more of a .beta..sub.2-agonist, ipatropium bromide, a steroid, a cromone, heparin, DNAse, leukotrienes, or insulin.

10. The pharmaceutical composition as claimed in claim 8, which is a dry powder and is suitable for use in a dry powder inhaler.

11. The pharmaceutical composition as claimed in claim 8, which comprises carrier particles.

12. The pharmaceutical composition as claimed in claim 11, which comprises the composite excipient particles in an amount of 1 to 40% based on the weight of the carrier particles.

13. The pharmaceutical composition as claimed in claim 11, in which the carrier particles have a fissured surface.

14. The pharmaceutical composition as claimed in claim 13, in which the carrier particles are of a crystalline sugar having a tapped density not exceeding 0.75 g/cm.sup.3.

15. The pharmaceutical composition as claimed in claim 13, in which the carrier particles have a bulk density as measured by mercury intrusion porosimetry of not exceeding 0.6 g/cm.sup.3.

16. The pharmaceutical composition as claimed in claim 11, in which the carrier particles have a MMAD of at least 175 .mu.m.

17. The pharmaceutical composition as claimed in claim 8, which comprises a propellant and is suitable for use in a pressurised metered dose inhaler.

18. A dry powder inhaler comprising a pharmaceutical composition as claimed in claim 8.

19. A pressurised metered dose inhaler comprising a pharmaceutical composition as claimed in claim 17.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc